Recombinant growth hormone-albumin fusion protein (Younuojin Biotech)

人血白蛋白-生长激素融合蛋白(优诺金生物工程)

Report date: 2024/05/23 20:00:04

Base Information

Drug NameRecombinant growth hormone-albumin fusion protein (Younuojin Biotech)
Drug Alias Name注射用重组人血白蛋白-生长激素融合蛋白
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsGrowth hormone deficiencyGrowth Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Inactive CompaniesN/A
Active IndicationsGrowth hormone deficiencyGrowth Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A